NeoGenomics announced on August 7, 2025, that it provides specialized cancer diagnostic testing services.
3 reports, 3 independent
Updated Aug 30
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
NeoGenomics announced on August 7, 2025, that it provides specialized cancer diagnostic testing services.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
NeoGenomics
cancer genetics diagnostic testing company based in Fort Myers, Florida, USA
Related events
Coverage
Newest first; wire copies grouped- tickerreport.com
- StockStory1 Small-Cap Stock with Exciting Potential and 2 We Ignore Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these
- Business WireNeoGenomics Reports Second Quarter 2025 Results Second Quarter Revenue Increased 10% to $181 million; Clinical Revenue Grew 16%, 13% excluding Pathline; Updates Full Year 2025 Guidance FORT MYERS, Fl